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Introduction: Exercise testing has become a diagnostic standard in the evaluation and
management of heart disease. While different methods of exercise and pharmacological
stress testing exist, only little is known about their comparability. We aimed to assess
hemodynamic changes during dynamic exercise, isometric exercise, and dobutamine
stress testing at different stress intensities in healthy subjects and patients with aortic
stenosis (AS) and aortic coarctation (CoA).
Methods: A systematic literature search (PROSPERO 2017:CRD42017078608) in
MEDLINE of interventional trials was conducted to identify eligible studies providing
evidence of changes in hemodynamic parameters under different stress conditions
acquired by MRI or echocardiography. A random effects model was used to estimate
pooled mean changes in hemodynamics.
Results: One hundred and twenty-eight study arms with a total of 3,139
stress-examinations were included. In healthy subjects/(where available) in
AS, pooled mean changes (95% CIs) during light dynamic stress were 31.78
(27.82–35.74) bpm in heart rate (HR) and 6.59 (2.58–10.61) ml in stroke volume
(SV). Changes during light pharmacological stress were 13.71 (7.87–19.56)/14.0
(9.82–18.18) bpm in HR, and 5.47 (0.3–10.63)/8.0 (3.82–12.18) ml in SV. Changes
during light isometric stress were 18.44 (10.74–26.14)/5.0 (−1.17–11.17) bpm
in HR and −4.17 (−14.37–6.03)/−4.0 (−16.43–8.43) ml in SV. Changes during
moderate dynamic stress were 49.57 (40.03–59.1)/46.45 (42.63–50.27) bpm
in HR and 11.64 (5.87–17.42) ml in SV. During moderate pharmacological
stress, changes in HR were 42.83 (36.94–48.72)/18.66 (2.38–34.93) bpm
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and in SV 6.29 (−2.0–14.58)/13.11 (7.99–18.23) ml. During high intensity dynamic
stress changes in HR were 89.31 (81.46–97.17)/55.32 (47.31–63.33) bpm and in
SV 21.31 (13.42–29.21)/−0.96 (−5.27–3.35) ml. During high pharmacological stress,
changes in HR were 53.58 (36.53–70.64)/42.52 (32.77–52.28) bpm, and in SV 0.98
(−9.32–11.27)/14.06 (−1.62–29.74) ml. HR increase and age were inversely correlated
at high stress intensities. In CoA, evidence was limited to single studies.
Conclusion: This systematic review and meta-analysis presents pooled hemodynamic
changes under light, moderate and high intensity exercise and pharmacological stress,
while considering the potential influence of age. Despite limited availability of comparative
studies, the reference values presented in this review allow estimation of the expected
individual range of a circulatory response in healthy individuals and patients with AS and
may contribute to future study planning and patient-specific models even when stress
testing is contraindicated.
Keywords: hemodynamics, exercise testing, dobutamine stress, healthy subjects, aortic stenosis, aortic
coarctation, meta-analysis, systematic review
INTRODUCTION
Cardiac stress testing is a major diagnostic tool in the evaluation
of heart disease (1). Stress testing in combination with imaging
techniques is not only recommended by current guidelines to
unmask myocardial ischemia (2), it is also used in valvular
heart disease (3) and decision making processes in congenital
heart disease (4, 5). Several methods for measuring physiological
responses to stress and exercise exist, including dynamic and
isometric exercise as well as pharmacological stress testing (6, 7),
and a lack of comparability between different stress laboratories
and populations has been noted (8).
While dynamic stress testing is generally considered the most
physiological type of stress (7), it is time consuming and of
limited use in some situations, e.g., in patients who are unable
to exercise adequately (9). Furthermore, this method requires
standardized equipment, with a lack of comparability between
different diagnostic set-ups having been described as problematic
(8). The combined use of dynamic stress testing with non-
invasive imaging procedures such asmagnetic resonance imaging
(MRI) or echocardiography has been limited due to motion
artifacts (9–11).
Pharmacological stress testing can be indicated when dynamic
testing cannot be performed due to the state of disease or the
setting of the examination. Dobutamine is widely used as a
pharmacological stressor to assess the hemodynamic response
in valvular heart disease, including aortic stenosis (AS), and in
congenital heart disease (3, 12, 13). Through its main effects
on myocardial beta-1 adrenergic receptors and its additional
effects on alpha-1 and beta-2 receptors, dobutamine leads to
a positive inotropic and chronotropic reaction and may also
involve minor vasodilating effects (14, 15). Through its effects
on heart rate (HR), stroke volume (SV), and vascular resistance
it can be used to simulate responses similar to those measured
during dynamic exercise (16). However, the effect of dobutamine
is possibly subject to changes at higher doses, resulting in a
further rise in HR with reduced diastolic filling time and lower
end-diastolic volumes. At the point where compensation by
a corresponding decrease in end-systolic volume is no longer
possible, the increased SV begins to fall whereas further increases
in cardiac output (CO) are mainly caused by a rise in HR, as
previously reported for healthy controls receiving incremental
dobutamine infusion (17).
Cardiovascular effects of isometric exercise testing have been
described since the early 1960s (18). Squeezing a handgrip
dynamometer can be performed easily without causing artifacts
affecting image quality, and MRI-safe handgrip devices have
accordingly become more popular during the past decades
(19, 20). Nevertheless, isometric exercise mainly imposes
high afterload on the ventricle, distinguishing it from the
hemodynamic reactions during dynamic exercise (6, 21). While
its potential role in the evaluation of coronary artery disease has
been described (22), current guidelines do not recommend the
routine use of isometric exercise in cardiac diagnostics (2, 23).
In AS and aortic coarctation (CoA), a congenital narrowing
of the aorta, dynamic, and pharmacological stress testing was
included in clinical guidelines for the assessment of pressure
gradients and cardiovascular responses (24, 25). In AS, the
information obtained from stress testing is used in the decision-
making process for the timing of surgical or interventional
treatment procedures (26, 27). Patients with AS–even when
asymptomatic–are known to show abnormal hemodynamic
responses with a lower SV and CO than controls (28). In CoA,
pharmacological dobutamine stress can be useful in order to
maintain adequate blood pressure and HR in patients who
are anesthetized or sedated during the heart catheterization
procedure, allowing reliable measurement of pressure gradients
before and after treatment (29, 30).
Physiological simulations and computational models
carry promising potential to provide further insights into
hemodynamic interactions between cardiac, vascular, and
neurohumoral responses (31, 32). In order to bring such tools to
Frontiers in Cardiovascular Medicine | www.frontiersin.org 2 April 2019 | Volume 6 | Article 43
Runte et al. Hemodynamic Changes During Stress Testing
diagnostic relevance and to simulate disease specific responses
they need to be capable of correctly simulating common stress
activity levels. Reliable values of stress-induced changes in HR,
SV, and CO as well as systolic ejection time (SET) and time to
peak aortic flow (TTP) are of particular interest for advanced
diagnostics. The quality of existing evidence reporting on these
parameters remains largely unknown. We aimed to summarize
hemodynamic changes caused by dynamic exercise, isometric
exercise, and pharmacological stress testing at different stress
intensities in healthy subjects, patients with AS, and patients
with CoA by synthesizing available evidence.
MATERIALS AND METHODS
Search Strategy
A review protocol was developed and publicized on the
PROSPERO register of systematic reviews (PROSPERO
2017:CRD42017078608). The protocol was developed with
the aim of identifying all studies in which evidence of the
hemodynamic parameters HR, SV, CO, SET, or TTP under
resting and stress conditions for dynamic, isometric, and
pharmacological stress testing could be found in healthy
individuals, patients with AS and patients with CoA. We focused
on studies reporting hemodynamic parameters acquired by MRI
or echocardiography. Outlines of the questions addressed by
this review are shown in the standardized scheme addressing
patient population, interventions, comparators, outcomes, and
study design (PICOS) in Table 1. No previous meta-analyses
addressing these specific questions were identified. The search
was conducted by a member of the research team (KR) in
MEDLINE (via PubMed) using previously specified search terms
(Table S1 in the data supplement). No relevant deviations were
found compared to an Embase query. Publications known from
preliminary searches were added. Date of the final search was 05
November 2017.
TABLE 1 | PICOS scheme.
PICOS
Patient population Healthy controls undergoing MRI or echocardiography
Aortic coarctation patients undergoing MRI or
echocardiography
Aortic stenosis patients undergoing MRI or echocardiography
Interventions Dynamic exercise
Dobutamine infusion
Isometric exercise
Comparators Resting state
Outcomes Primary
Heart rate [bpm]
Blood flow/stroke volume [ml]
Cardiac output [l/min]
Additional
Systolic ejection time [ms]
Time to peak aortic flow rate [ms]
Study design Interventional studies with or without control group
Study Selection and Quality Assessment
Studies that met the inclusion criteria (as set out in the
PICOS table) were included. Eligible records were reports of
interventional studies, either with or without a control group.
They were included in the quantitative analysis if at least HR and
another outcome parameter (SV, CO, SET, TTP) under resting
and stress conditions could be extracted. We limited our search
to studies published after 1985 to avoid errors in measurements
resulting from lower diagnostic accuracy of outdated imaging
devices. Exclusion criteria were met when studies were not
available in English, German nor as full texts within the
institutional subscriptions or the National Library license or were
not conducted in humans. Furthermore, we excluded studies that
(a) had measurement locations other than the ascending aorta or
the left ventricle, (b) used other measurement techniques than
MRI or echocardiography, or (c) if stress types were not dynamic
exercise, upper-limb isometric exercise, or dobutamine infusion
as pharmacological stress. Study arms with <10 subjects were
not included. Reviews, letters, comments, conference posters,
and single case reports were excluded. Following the criteria
described, articles were scanned on title and abstract level before
full texts were retrieved. In studies providing evidence of different
cohorts or intensity levels, every cohort and intensity level was
included as a separate study arm. Each study was assessed using
a modified version of the Downs and Black checklist (33). The
tool was chosen as recommended by the Cochrane handbook
for assessing the methodological quality of non-randomized
studies (34) and was suitable for different study types. We
adapted the checklist by excluding irrelevant items according
to study type and characteristics. Each study was assessed for
reporting (1–4, 6–8, 10), external validity (11–13), internal
validity including study and selection bias (16, 19–22), and power
(27). Studies involving a control group were additionally assessed
on distribution and adjustment for confounding variables (5, 25).
Whenever follow-up was part of a study, losses to follow-up were
evaluated (9). Each paper was reviewed by one reviewer (CS) and
verified by a second reviewer (KR). Cases of disagreement were
discussed with a third reviewer (MK). Cut-offs were determined
by dividing the maximum possible points into thirds. Therefore,
a study in which 17 or 18 items were assessed was considered to
be of low methodological quality if it achieved 0 to 5 points, of
moderate quality if it achieved 6 to 10 points and of high quality
at more than 11 points. In cases of 19 or 20 applicable items a
study was judged to have low quality when the score was 0 to 6,
moderate quality when it was 7 to 13 points and high quality with
a score above 14 points.
Data Extraction
Data were extracted by a member of the research team (KR).
Means and standard deviations of HR, SV, CO, SET, and TTP
were used if available under resting and stress conditions. If
no information on the variance was available, studies were not
included in the analysis. If studies provided indexed stroke
volume or the cardiac index and body surface area (BSA),
the absolute SV and CO were calculated. The data extracted
also included the description of study participants (sex, age,
BSA, BMI, state of disease, and left-ventricular function),
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characteristics of the interventions as to type and intensity of the
stress test and the image modality used.
Intensity Classification
Studies were categorized as light, moderate and high intensity
according to intensity classifications of dynamic exercise. The
following indications provided the basis for classification of
stress intensity:
1) Metabolic equivalents (METs) (35),
2) Intensity in watts (W) during ergometric exercise (assuming
a body weight of 60–80 kg) (35),
3) Stage of standard Bruce protocol during treadmill
exercise (7)
4) Percentage of age predicted maximal heart rate
(HRmax = 220–age in years) (36),
5) Statement of study authors about the intensity level.
Following Jetté et al. we considered an intensity of ≤4 METs as
light, 5 to 8 METs as moderate and >8 METs as high intensity.
The equivalence of watts to METs can be assumed as follows for a
person with a body weight of 60–80 kg: 50W , 3.2–4.3 METs;
75W , 4.3–5.7 METs; 100W , 5.4–7.1 METs; 125W , 6.4–
8.6 METs; 150W , 7.5–10 METs (35). For the standard Bruce
protocol similar assumptions were made: Stage 1 , 4.5 METs;
Stage 2 , 7 METs; Stage 3 , 10.5 METs (7). In accordance with
common classifications, intensity of pharmacologic stress was
considered as light for low dose infusion of dobutamine of 0–10
µg/kg/min, as moderate for 11–20 µg/kg/min and as high for a
dose exceeding 20µg/kg/min (12, 37–39). Isometric exercise tests
were always classified as light intensity because static contraction
causes only little increase in HR or CO while it mainly affects
mean arterial pressure and is not expected to reach the changes
of higher levels of dynamic exercise (21). Applying these criteria
we created the stress intensities represented in Table 2.
Statistical Analysis
Primary outcomes were pooled mean differences of HR, SV,
CO, and SET between resting and stress conditions. TTP had
to be excluded from further analysis as this parameter was
only reported in a total number of 5 studies. Pairwise meta-
analysis was performed in studies directly comparing different
types of stress. Where only single arm data were available, study
arms were grouped according to stress type and intensity level
and meta-analyzed to obtain pooled estimates of hemodynamic
changes. An additional analysis of subgroups was performed in
patients with AS and impaired LV function. Mean differences of
hemodynamic parameters between rest and stress and respective
standard errors of the difference between means were calculated
(40). Differences between baseline characteristics of study arms
grouped according to stress type were checked by Kruskal-Wallis
test, followed by Dunn’s test with Bonferroni correction where
appropriate. We quantitatively synthesized effects reported in
individual studies using a DerSimonian-Laird random effects
model (41), as implemented in the “metan” suite of commands
in Stata (42). However, this model does not take into account
uncertainty in the between-study variance and as a result may
underestimate uncertainty of the pooled effect size for samples
TABLE 2 | Intensity levels of stress testing.
Intensity Dynamic
exercise
Dobutamine
stress
Isometric
exercise
Light METs: ≤ 4 METs 0–10 µg/kg/min All
Ergometer: 50W
Treadmill: Stage 1 BP
HRmax: ≤ 54%
Statement: Light
Moderate METs: 5–8 METs 11–20 µg/kg/min –
Ergometer: 75–125W
Treadmill: Stage 2 BP
HRmax: 55–84%
Statement: Submaximal/
moderate
High METs: > 8 METs >20 µg/kg/min –
Ergometer: > 125W
(<70 kg: >
100W)
HRmax: ≥ 85%
Symptoms
Treadmill: ≥ stage 3 BP
HRmax: ≥ 85%
Statement: Exhaustion
METs indicates metabolic equivalents (1MET = 3.5ml O2kg
−1min−1); W, watt; BP,
standard Bruce protocol; HRmax , age-predicted maximal heart rate (= 220–age in years).
of studies with high heterogeneity (43). Since we observed high
heterogeneity in the results obtained by the DerSimonian-Laird
random effects models, we re-ran the analyses with random
effects models that use alternative estimators of between-study
variance, specifically a restricted maximum likelihood model
(44), profile likelihood model (43, 45), and permutations random
effects model (46). These models were run as implemented in the
“metan” suite of commands in Stata (47). The results obtained
from the various models did not differ in any meaningful way
from our primary analysis using the DerSimonian-Laird model
for either pooled effect size or uncertainty and we therefore only
present the results from the pre-planned, primary analysis. We
used the Q-statistic to test for statistical heterogeneity. However,
since we anticipated a low number of studies for at least some
of the intervention-outcome pairs for which meta-analyses were
conducted, and generally small sample sizes in individual studies,
we did not rely exclusively on the Q-statistic as a measure
of heterogeneity. Between-study heterogeneity was also visually
assessed through forest plots for all interventions and outcomes,
and we quantified the proportion of between-study variation due
to true heterogeneity as compared to chance alone through the
I2 statistic (48). Having fitted random-effects models, as per our
prior considerations regarding underlying variations in included
studies, we then used the I2 to assess the appropriateness of
this selection (49), taking I2 values of 30% or over to indicate
potential significant true heterogeneity (50). Results are shown
as absolute mean changes and 95% confidence intervals (CIs)
between resting and stress conditions for the different types and
intensities of stress. Results of individual studies and pooled
estimates for each stress type and intensity are provided in
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forest plots in the Supplementary Material. We considered
the differences between pooled changes for the different stress
types as significant if no overlap of their confidence intervals
was seen according to Cochrane Collaboration standards (50).
A multivariate meta-regression model was used to determine
variables potentially influencing outcome parameters. As studies
with a wide age range were included, starting from school-
aged children, meta-regression analysis was performed to
assess the impact of age across the included age spectrum.
Potential correlations were investigated through univariate meta-
regression. Meta-analyses were executed in STATA, version
15.1 (StataCorp, College Station, Texas, USA), by using the
metan package.
RESULTS
Systematic Review
The database search resulted in a total of 1,188 references. After
screening on title and abstract level, 234 full texts were retrieved.
After full-text screening, 83 studies with a total of 128 study arms
and 2,812 subjects, and 3,139 stress examinations were included.
Details of the study selection process can be found in the PRISMA
flow chart (Figure 1) and in the list of included studies in the
supplemental material (Tables S2–S4).
For healthy individuals, we found 3 studies (6 study arms)
directly comparing dynamic exercise with dobutamine infusion
and 2 studies (6 study arms) comparing dynamic with isometric
exercise. Additional single study arms were included, resulting
in a total of 64 study arms (1,448 stress examinations) for
dynamic exercise, 33 study arms (445 stress examinations)
for pharmacological stress, and 8 study arms (229 stress
examinations) for isometric exercise for pooled analysis (details
in Figure S1 in Data Supplement).
For AS, 11 study arms (755 stress examinations) were
included for dynamic, 6 study arms (161 stress examinations)
for pharmacological ,and 1 study arm (22 stress examinations)
for isometric stress test. For CoA, evidence was limited to a
total number of 5 study arms (79 stress examinations) and no
meaningful quantitative analysis of our pre-specified outcomes
was possible.
Study Characteristics
Baseline characteristics for healthy individuals undergoing
dynamic, dobutamine, and isometric stress tests are shown
in Table 3. Subjects in the dynamic exercise group were
significantly younger and had a lower body mass index than
subjects in the pharmacological or isometric stress group. Four
studies (59 patients) in the dynamic exercise group investigated
hemodynamic changes in children younger than 18 years.
Baseline characteristics for AS can be found in Table S5 in
the data supplement. AS was classified as (a) asymptomatic or
symptomatic with preserved left ventricular ejection fraction
(LV-EF) (877 patients), and (b) low-flow, low-gradient AS with
reduced LV-EF (61 patients). While reporting on severity was
inconsistent between studies, group (a) contained studies where
the need for aortic valve replacement and the presence of severe
AS was mentioned (50 patients) and studies where severity
ranged from mild to severe (72 patients). All other studies in (a)
were in patients with moderate to severe asymptomatic AS.
Quality Assessment
Using the modified Downs and Black checklist 32 studies were
judged to be of high methodological quality and 51 of moderate
quality. None of the studies included was of low quality. The
final quality score of each study is reported in Tables S2–S4 in
the data supplements. A detailed overview of all items and their
scores is provided in Table S8. The highest scores were achieved
in the items pertaining to reporting details and internal validity.
All studies reported their aims, hypothesis and main outcomes
clearly. Compliance was consistently reliable. Low scores were
achieved in external validity and selection bias, as information
on selection method, place, and time period of participants’
recruitment were rarely given. Moreover, small sample size was
a clear limitation of most studies. A calculation of power was
done in only 3 studies. Despite these drawbacks, every study was
considered appropriate for the aims of this investigation.
Pooled Rest-Stress Changes From Single
Arm Studies for Healthy Subjects
Absolute mean changes and 95% CIs of HR, SV, CO, and
SET of healthy subjects are visualized in Figure 2 (details in
supplemental forest plots: Figures S2–S13).
Light dynamic exercise increased HR by 31.78 bpm (95%
CI, 27.82 to 35.74; I2 = 75.2%), SV by 6.59ml (95% CI, 2.58
to 10.61; I2 = 40.1%) and CO by 2.68 l/min (95% CI, 1.72 to
3.64; I2 = 90%) compared to resting baseline values. SET of
the left ventricle was shortened by −20.92ms (95% CI, −45.62
to 3.78; I2 = 80.5%). Low dose infusion of dobutamine (5–10
µg/kg/min) resulted in changes of 13.71 bpm (95% CI, 7.87 to
19.56; I2 = 88.6%), 5.47ml (95% CI, 0.3 to 10.63; I2 = 0.0%),
1.54 l/min (95% CI, 0.69 to 2.38; I2 = 79.4%) for HR, SV,
and CO, respectively (no studies available for changes in SET).
Pooled changes of isometric exercise were 18.44 bpm (95% CI,
10.74 to 26.14; I2 = 95.6%), −4.17ml (95% CI, −14.37 to 6.03;
I2 = 81.7%), 0.82 l/min (95% CI, −0.26 to 1.9; I2 = 89.2%), and
−0.38ms (95% CI, −19.07 to 18.32; I2 = 89.4) for HR, SV, CO,
and SET, respectively.
In the moderate intensity group pooled estimates of changes
in HR were 49.57 bpm (95% CI, 40.03 to 59.1; I2 = 97.0%), in SV
were 11.64ml (95% CI, 5.87 to 17.42; I2 = 75.9%), and changes
in CO were 4.67 l/min (95% CI, 3.5 to 5.84; I2 = 95.3%) for
dynamic exercise. For moderate dosage of dobutamine (11–20
µg/kg/min) changes in HR were 42.83 bpm (95% CI, 36.94 to
48.72; I2 = 94.5%), in SV were 6.29ml (95% CI, −2.0 to 14.58;
I2 = 60.0%), and in CO were 4.42 l/min (95% CI, 3.65 to 5.19;
I2 = 80.9%). SET decreased by −51.59ms (95% CI, −100.58 to
−2.61; I2 = 88.9%) in the moderate dynamic exercise group.
High dynamic exercise resulted in a mean increase of 89.31
bpm (95% CI, 81.46 to 97.17; I2 = 97.6%) in HR, 21.31ml (95%
CI, 13.42 to 29.21; I2 = 91.1%) in SV, 10.45 l/min (95% CI, 8.04
to 12.85; I2 = 98.9%) in CO and a decrease of −77.83ms (95%
CI, −95.88 to −59.78; I2 = 85.6%) in SET. For high dosage
of dobutamine (21–40 µg/kg/min) HR increased by 53.58 bpm
(95% CI, 36.53 to 70.64; I2 = 98.4%), SV by 0.98ml (95% CI,
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FIGURE 1 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart. *One study that was included had different study arms as well
for healthy individuals and for aortic stenosis (Donal, January 2011), which explains the different number of total studies included.
−9.32 to 11.27; I2 = 52.5%), CO by 4.98 l/min (95% CI, 2.94
to 7.01; I2 = 90.4%), and SET decreased by −90.0ms (95% CI,
−103.71 to−76.29; only reported in one study).
Heterogeneity of Results and Relationship
With Intensity and Age
Significant between-study heterogeneity was found in all meta-
analyses for changes in HR, SV, CO, and SET in healthy
individuals (Smallest I2 = 65.7%; p < 0.01), except for SV
analyses in the light dynamic, light pharmacological, and high
pharmacological group. A visual representation of heterogeneity
is available in supplemental forest plots S2–S13. Multivariate
meta-regression showed that intensity level was statistically
significantly associated with changes in HR (p < 0.001). Study
arms with older participants had lower changes in HR (p <
0.05). None of the other covariates tested (intervention type,
athlete, or health status) showed a significant association with
changes in HR (p = 0.14; p = 0.13; p = 0.22, respectively).
Multivariate estimates of systematic association of covariates
with changes in HR are available in supplemental Table S7.
Univariate meta-regression at different intensity levels showed
a significant relationship between age and HR changes in high
intensity stress testing, where older age was associated with lower
changes in HR (p < 0.001; R2 = 72.14%). Under high intensity,
the heart rate change decrease was 1.14 bpm (95% CI, 0.708 to
1.571) for each year of life. No significant age-dependency of
HR changes was found in light and moderate intensity stress
groups (p = 0.685 and p = 0.534, respectively). No significant
correlation of age and changes in SV or CO was observed at any
intensity level (p > 0.05). Corresponding meta-regression plots
are presented in Figure 3. Four studies included children below
the age of 18 years, starting from school age. Univariate meta-
regression showed no significant correlation of mean resting HR
and corresponding HR changes throughout all intensity levels (p
> 0.05). No significant correlation of mean resting SV and SV
changes was found (p > 0.05) (Figure 4).
Comparative Studies
Only 3 studies directly compared pharmacological to dynamic
stress testing (51–53). Each of these studies showed lower
increases in HR, SV, and CO for dobutamine stress. Compared
to dynamic stress testing, pharmacological stress showed lower
mean change of HR (21.29 bpm, 95% CI−39.53 to−3.04), lower
change of SV (15ml, 95% CI −28.46 to −1.54; reported in one
study) and lower change of CO (5.22 l/min, 95% CI −9.63 to
−0.81). Two studies with 3 cohorts reported differences between
isometric and dynamic exercise (54, 55). Compared to dynamic
exercise, isometric exercise showed lower mean change of HR
(35.94 bpm, 95% CI−64.31 to−7.57), higher change of SV (2ml,
95% CI −53.31 to 57.31), lower change of CO (8.20 l/min, 95%
CI −12.85 to −3.55) and higher change of SET (30.56ms, 95%
CI −36.07 to 97.16). Corresponding forest plots are available in
the supplemental material (Figures S19–S25).
Aortic Stenosis
Overall pooled mean changes and 95% CIs in HR, SV, CO,
and SET of patients with AS can be found in Table S6 in
the data supplement and in the corresponding forest plots
(Figures S14–S18).
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TABLE 3 | Baseline characteristics for healthy individuals.
Dynamic exercise Pharmacological stress Isometric exercise Krus-kal-
Wallis-Test
Study arms reporting
variable (N of tests)
Study arms reporting
variable (N of tests)
Study arms reporting
variable (N of tests)
P-Value
Total N of stress tests 64
(1,448)
33
(445)
8
(229)
Age, years 30†
(24.3–51.1)
61
(1,397)
51†
(28.5–58)
28
(395)
46.5
(32.7–53.5)
8
(229)
0.02*
Male, % 71.7
(46.2–100)
62
(1,420)
50.0
(40.6–75.0)
27
(384)
83.3
(58.0–100)
7
(217)
0.09
BSA, m2 1.87
(1.8–1.9)
22
(572)
1.85
(1.82–1.9)
5
(90)
1.9
(1.9–1.9)
1
(18)
0.69
BMI, kg/m2 23.6†, ‡
(22.2–24.8)
39
(854)
25.0†
(23.9–26.2)
8
(122)
25.1†, ‡
(24.6–25.5)
6
(169)
0.01*
Resting HR, bpm 69
(64–74)
55
(1,256)
66
(66–71)
33
(445)
68.5
(64–73)
8
(229)
0.87
Resting SV, ml 75.5
(64–93)
32
(766)
93
(70–101)
18
(231)
81.8
(71–106)
4
(101)
0.18
Resting CO, l/min 5.5
(4.8–6.2)
37
(837)
5.7
(5.5–6.6)
22
(277)
5.4
(3.9–8.3)
3
(83)
0.53
Resting SET, ms 294
(281–308)
10
(207)
270
(270–270)
1
(20)
283
(269–303)
4
(96)
0.35
Light intensity, % 15.7 12
(228)
23.6 10
(105)
100 8
(229)
Moderate intensity, % 26.9 20
(389)
46.1 15
(205)
High intensity, % 57.4 32
(831)
30.3 8
(135)
Children, % 5.5 5
(79)
Athletes, % 12.7 9
(184)
Values are reported as median (interquartile range). BMI indicates body mass index; BSA, body surface area; HR, heart rate; SV, stroke volume; CO, cardiac output; SET, systolic
ejection time.
*p < 0.05 overall.
†
p < 0.05 in pairwise comparison of dynamic exercise and pharmacological stress (Dunn’s test).
‡p < 0.05 in pairwise comparison of dynamic exercise and isometric exercise (Dunn’s test).
Light pharmacological stress caused changes in HR of 14 bpm
(95% CI 9.82 to 18.18; I2 = 0%), in SV of 8ml (95% CI 3.82
to 12.18; I2 = 0%), of CO in 1.33 l/min (95% CI 1.11 to 1.55;
I2 = 0%), and in SET of −41ms (95% CI −52.29 to −29.71;
I2 = 0%). Isometric stress caused changes in HR of 5 bpm (95%
CI −1.17 to 11.17; I2 = 0%), in SV of −4ml (95% CI −16.43
to 8.43; I2 = 0%), and in CO of 0.21 l/min (95% CI −0.64 to
1.06; I2 = 0%).
During moderate dynamic stress values of pooled HR changes
were 46.45 bpm (95% CI 42.63 to 50.27; I2 = 40.6%). During
moderate pharmacological stress changes in HR were 18.66
bpm (95% CI 2.38 to 34.93; I2 = 89.2%). During moderate
pharmacological stress changes in SV were 13.11ml (95% CI
7.99 to 18.23; I2 = 0%), in CO 1.7 l/min (95% CI 0.74 to
2.66) and in SET −40.0ms (95% CI −45.33 to −34.67). After
excluding the two studies with low-flow, low-gradient AS with
consecutive LV-EF impairment from analysis of the moderate
pharmacological stress level, the changes during moderate
pharmacological stress in HR were 18.0 bpm (95% CI 0.47
to 35.53; I2 = 0%) and in SV 9.0ml (95% CI −2.69 to
20.69; I2 = 0%). In patients with low-flow, low-gradient AS
with LV-EF impairment pooled HR changes during moderate
pharmacological stress were 18.92 bpm (95% CI −2.64 to 40.48;
I2= 94.6%) and pooled SV changes were 14.09ml (95%CI 8.39 to
19.79; I2 = 0%).
Changes during high intensity dynamic stress were HR 55.32
bpm (95% CI 47.31 to 63.33; I2 = 91.9%), SV −0.96ml (95%
CI −5.27 to 3.35; I2 = 17.1%), CO 5.3 l/min (95% CI 3.46 to
7.14; I2 = 84.2%), and SET −58.94ms (95% CI −127.52 to 9.63;
I2 = 92.5%). During high pharmacological stress changes were
HR 42.52 bpm (95% CI 32.77 to 52.28; I2 = 59.1%), SV 14.06ml
(95% CI−1.62 to 29.74; I2 = 85.2%), and CO 3.92 l/min (95% CI
2.45 to 5.39; I2 = 78.5%).
Insufficient data were available to conduct extensive subgroup
analyses for intensity levels in patients with AS. Data of the
light intensity group of pharmacological and isometric stress
were derived from only a single study, respectively, and no
data at all were found for patients with AS undergoing light
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FIGURE 2 | Pooled mean changes and 95% CIs in healthy individuals under stress conditions for (A) HR Change: absolute changes in heart rate in beats per minute
(bpm). (B) SV Change: absolute changes in stroke volume in ml. (C) CO Change: absolute changes in cardiac output in liters per minute (l/min). (D) SET Change:
absolute changes in systolic ejection time in milliseconds (ms). Bubble size is proportional to the number of stress examinations included (N).
dynamic exercise. In the moderate dynamic exercise group
only changes in HR were available; in the corresponding
pharmacological stress group changes in HR and SV were
estimated based on three studies, while CO and SET changes
are based on a single study. High intensity level changes
are based on data of 10 studies. In contrast to findings in
healthy subjects, SV decreased in AS under maximal dynamic
exercise, but increased for high levels of dobutamine infusion
(>20 µg/kg/min).
Aortic Coarctation
Only four studies in patients with surgically repaired CoA could
be found, but none was identified in patients with native CoA.
None of the screened studies met all of the pre-specified inclusion
criteria as studies (a) did not report the parameters of interest,
and (b) used other types of stress tests as well as (c) different
imaging modalities. Findings are therefore limited to few single
studies of interest: Pedersen et al. found an increase of 1.5
l/min/m2 (1 to 1.7) and 2.4 l/min/m2 (2 to 2.9) (median and
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FIGURE 3 | Univariate meta-regression analyses investigating age dependency of absolute mean changes of HR, SV, and CO in healthy subjects for all stress
intensities. First row: age dependency of HR changes for light intensity (coefficient −0.078, p = 0.685, adjusted R2= 0%), moderate intensity (coefficient −0.095,
p = 0.534, adjusted R2= 0%) and high intensity (coefficient −1.139, p < 0.001, adjusted R2 = 72.14%). Second row: Age dependency of SV changes for light
intensity (coefficient 0.055, p = 0.767, adjusted R2 = 0%), moderate intensity (coefficient 0.059, p = 0.68, adjusted R2 = 0%) and high intensity (coefficient 0.01,
p = 0.964, adjusted R2 = −7.81%). Third row: Age dependency of CO changes for light intensity (coefficient −0.007, p = 0.967, adjusted R2 = 0%), moderate
intensity (coefficient 0.034, p = 0.813, adjusted R2 = 0%), and high intensity (coefficient −0.034, p = 0.849, adjusted R2 = 0%). Bubble size indicates study
sample size.
ranges) in cardiac index for CoA patients after ascending-to-
descending aortic bypass surgery, performing ergometer exercise
with 0.5 and 1 W/kg, respectively, and reported no difference
to healthy controls (56). Kimball et al. reported an increase of
70.8 bpm (95% CI 59.89 to 81.71) in HR and 14.3% (95% CI
7.87 to 20.73) in ejection fraction induced by maximal exercise
in repaired CoA (57). Carpenter et al. found an increase in HR
of 63 bpm (95% CI 53.87 to 72.13) and stated that patients with
CoA show hyper-dynamic left ventricular function compared
to healthy controls (58). Only one study so far investigated
dobutamine stress echocardiography in patients with aortic
coarctation, but focused on pressure gradients and did not
report pre-defined hemodynamic parameters (30). Weber et al.
used intravenous isoproterenol infusion (0.05–0.1 µg/kg/min)
as pharmacological stress test instead of dobutamine resulting
in a mean increase of 65 bpm (95% CI 49.37 to 80.63) in
HR, 3.36 l/min (95% CI 0.48 to 6.24) in CO, and 22 mmHg
(95% CI 15.17 to 28.83) in pressure gradients in patients
with repaired CoA, but persistent hypertension during exercise
testing (59).
DISCUSSION
In this systematic review and meta-analysis, we present pooled
data on hemodynamic changes elicited by three commonly used
methods of stress testing in clinical practice. While several
studies exist that evaluate hemodynamic parameters under stress
conditions in healthy individuals, evidence is still limited in
disease groups for which hemodynamic changes are important
parameters for treatment decisions (AS and CoA). Furthermore,
there is great heterogeneity of stress testing methods and
patient cohorts.
In healthy individuals and AS, intensity dependent increases
in HR and CO were observed as well as further decreases in SET
at each intensity level. In healthy subjects, increasing intensity
levels of dynamic exercise were associated with higher increases
in SV; light and moderate pharmacological stress caused some
increase of SV which did not differ significantly between the two
intensities, while high intensity pharmacological stress was not
associated with significant changes in SV from baseline. In AS,
high intensity dynamic exercise caused no significant change in
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FIGURE 4 | Univariate meta-regression analyses investigating the dependency of absolute mean changes of HR and SV of mean resting HR and mean resting SV in
healthy subjects for all stress intensities. First row: Correlation of mean resting HR and HR changes for light intensity (coefficient −0.653, p = 0.341, adjusted
R2 = 0%), moderate intensity (coefficient 0.022, p = 0.963, adjusted R2 = 0%) and high intensity (coefficient −0.995, p = 0.143, adjusted R2 = 3.45%). Second row:
Correlation of mean resting SV and SV changes for light intensity (coefficient −0.0367, p = 0.839, adjusted R2 = 0%), moderate intensity (coefficient −0.187, p =
0.36, adjusted R2 = 0%), and high intensity (coefficient −0.346, p = 0.096, adjusted R2 = 25.58%). Bubble size indicates study sample size.
TABLE 4 | Trends of changes in hemodynamic parameters in healthy individuals.
Type of stress HR SV CO SET Utility for
diagnostics
Light dynamic ↑↑ ↑ ↑ ↓ Daily life activity
Light pharmacological ↑ ↑ ↑ Imitate exercise
without patient
motion
Light isometric ↑ ←→ ↑ ←→ Ventricular
adaptation to
afterload
Moderate dynamic ↑↑↑ ↑↑ ↑↑ ↓↓ Daily life exercise
Moderate pharmacological ↑↑ ↑ ↑↑ Imitate exercise
without patient
motion
High dynamic ↑↑↑↑ ↑↑↑ ↑↑↑ ↓↓↓ Limits of exercise
capacity
High pharmacological ↑↑↑ ←→ ↑↑ (↓↓↓) Ischemia,
symptoms without
patient motion
HR indicates heart rate; SV, stroke volume; CO, cardiac output; SET, systolic ejection time.
↑, increase; ↓, decrease;←→, no change. Blanks indicate that no data were available.
Higher number of arrows indicates a more marked change of the respective parameter.
SV from baseline, while all levels of pharmacologic stress were
associated with a further increase in SV. Isometric exercise in
healthy individuals and AS was associated with a non-significant
trend to decreased SV compared to resting conditions. Only little
evidence was found for light and moderate intensity levels in
AS, as in these patients stress testing is mainly used to assess
maximal exercise capacity and unmask stress-induced symptoms
(3). Characteristic trends of changes in HR, SV, CO, and SET in
healthy subjects covering different types and intensity levels of
stress testing are summarized in Table 4.
In the clinical setting a variety of stress testing set-
ups are routinely used. More knowledge about comparability
would enable physicians to not only overcome barriers
between sites and protocols, but to bring methods closer to
standardization and interchangeability. Only few studies so far
have directly compared pharmacological stress and dynamic
exercise. They found lower increases of all outcome parameters
in pharmacological stress. The pooled mean changes from
single arm studies indicate that moderate intensity dynamic
and pharmacological stress result in similar increases in HR,
SV and CO with similar effect sizes and overlapping 95% CIs.
Compared to dynamic exercise, light intensity dobutamine stress
results in a similar increase in SV, but not in HR. While
high dose dobutamine stress does not cause increases in SV
it does cause significant increases in HR. As described in the
literature (14), these pooled values show that the inotropic
effects of dobutamine wear off with increasing doses while
the chronotropic reactions are preserved. While well-monitored
dobutamine stress testing is known to be generally safe, a low
incidence of complications including a risk for inducing cardiac
arrhythmias has been reported (60). It should therefore be
only used after careful consideration of clinical needs, non-
pharmacological alternatives, and under appropriate monitoring.
In direct comparison of isometric and dynamic exercise, lower
increases in HR, and CO under isometric exercise were found
while SV changes did not differ significantly. SET changes were
higher under isometric exercise, as SET tends to decrease during
dynamic exercise. Results of pooled single arm studies confirmed
that HR and CO increases were lower during isometric exercise,
while SV even decreased. The SET did not change significantly
during isometric exercise in contrast to a decrease of the SET
during light dynamic exercise. A possible explanation for this
may be that isometric exercise causes a rise in total systemic
vascular resistance, provoking higher mean arterial pressure,
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and thereby imposing an elevated afterload on the ventricle.
This results in an increase in stroke work without provoking
an absolute increase in SV (21). The elevated afterload is also a
potential explanation for why SET does not decrease in isometric
exercise (in contrast to dynamic exercise), as no acceleration of
ventricular contraction occurs when a higher resistance has to
be overcome.
In addition to the main differences between the three intensity
levels, smaller differences between the various types of stress were
also found. Meaningful differences in HR, SV, and CO changes
were observed between light intensity and high intensity levels.
The findings may indicate that stress tests lack comparability
at the respective intensity levels, and that equivalent use in
diagnostic settings could be misleading. Therefore, these results
can be of clinical value in order to plan an adequate type of
stress testing in an individual patient. On the other hand, changes
of hemodynamic parameters within one single stress level may
provide clusters showing to which degree changes in HR, SV, CO,
or SET correlate with light, moderate, and high intensity stress.
Loimaala et al. previously compared the effects of ergometric,
pharmacological, and isometric stress echocardiography in
patients with myocardial ischemia and showed that bicycle and
dobutamine tests are both accurate in the diagnostic process of
coronary artery disease, although resulting in different absolute
hemodynamic changes, but isometric stress was not feasible (61).
Our data are in line with this study showing that hemodynamic
changes of dobutamine stress and dynamic exercise show
similarities, especially in the moderate intensity levels. Pooled
hemodynamic effects of isometric exercise were different from
those of dynamic exercise affirming that this imposes a different
type of burden on the cardiovascular system (54).
With increasing age, the absolute changes in HR were lower
in the high intensity level. These findings are in line with
the previously described and commonly applied formula to
calculate the maximal heart rate of subjects considering their age
(HRmax = 220–age in years) (36).
Themajority of patients in the AS group had asymptomatic AS
under resting conditions or, in a minority of cases, low-flow, low-
gradient AS, as these conditions represent guideline indications
for stress testing in AS (13). Only a few of the stress tests included
were obtained in symptomatic patients with AS, all of which were
conducted during invasive treatment procedures. Neither the
presence of symptoms nor the low-flow, low-gradient AS differed
from the overall cohort. Nevertheless, we report data for low-
flow, low gradient AS with impaired ejection fraction separately,
as this patient group represents a relevant clinical subgroup with
altered ventricular mechanics. Patients with AS generally showed
lower increases of HR and CO during stress testing than healthy
persons and lower changes of SV during high intensity dynamic
exercise. In addition to the stenotic valve, patients with AS were
older and, due to their disease, could not reach the high stress
intensities or maximal HR of healthy individuals. Additionally,
AS impacts the myocardium and leads to maladaptive cardiac
remodeling with left ventricular hypertrophy that can evolve
into heart failure (62). Consequently, cardiac inotropy in AS is
reduced which may contribute to impaired CO from the left
ventricle. Surprisingly, our pooled results showed that high dose
pharmacological stress induced relatively strong increases in SV
in contrast to high intensity dynamic exercise in AS. As only
two studies were analyzed in the high intensity pharmacological
group, these particular findings remain questionable due to a
paucity of evidence.
While congenital heart disease only affects ∼1–2% of
the overall population (63), the numbers of grown-ups with
congenital heart disease are increasing and the availability of
reliable exercise-testing data for this group would be highly
beneficial as several approaches for non-invasive diagnostic
and treatment planning already exist (64, 65). Evidence in
patients with CoA is still limited to very few case series in
which hemodynamic changes cannot be properly compared to
pooled estimates from healthy subjects due to differences in
measurement variables and units as well as considerably younger
age of the patients investigated. As reflected in clinical routine
most patients with CoA had been previously treated at the
time of stress testing. Moreover, in CoA evidence regarding
HR changes was mainly limited to three case series and only
insufficient evidence was available regarding SV, CO, and SET
changes. Increases in HR were slightly lower for patients with
CoA undergoing high intensity dynamic exercise. One study
reported higher changes of HR and lower changes of CO for
high intensity pharmacological testing compared to the pooled
estimates in healthy individuals but using isoproterenol instead
of dobutamine as pharmacological agent. Qualitatively in one
study the authors concluded that there were no differences in
exercise reactions in patients with CoA compared to healthy
controls, whereas in the other three studies significant differences
were found. CoA is known to provoke altered baroreceptor
sensitivity (66), so that different hemodynamic adaptions to
stress are very likely, but accurate quantification of these
differences remains impossible due to the limited availability
of data.
Limitations
Available evidence is mainly restricted to observational trials
as only a few studies were available directly comparing
different stress types. The results of the comparative studies
seem to be in line with findings of single arm studies.
However, due to the higher cumulative number of subjects
in single arm studies, more detailed differentiations can be
made considering intensity levels. As these studies were not
primarily intended for such comparison, heterogeneity within
the same group of stress type and intensity was high, which
represents the main limitation of this study. Various factors
could have contributed to high between-study heterogeneity.
Differences in the baseline characteristics of each individual
cohort, including gender differences and individual fitness
levels, were difficult to assess, as these findings were not
consistently reported. However, we investigated the influence
of the subjects’ age and ratio of athletes through various meta-
regression analyses and found a significant association only for
mean age in the high intensity group, but not for the ratio
of athletes in the study. Nevertheless, these results should be
interpreted with caution, as meta-regression analyses only reflect
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mean values on a study-level instead of individual patient-
specific variations.
Although consensus guidelines on stress echocardiography
(9, 13) and exercise testing (7) exist, consistent recommendations
for recent approaches, such as MRI compatible exercise testing,
are missing and large diversity of stress protocols exists within
the analyzed studies. Relevant differences exist in the type of
exercise applied (treadmill vs. bicycle; handgrip vs. 2-hand-
bar dynamometer), the increment of workload and the end-
points determined by the investigators. It can be assumed that
this reflects current clinical practice across different centers,
limiting comparability. Furthermore, the posture of the subjects
during stress testing (supine during pharmacological stress and
ergometric exercise, semi-supine during ergometric exercise or
upright during isometric, ergometric, and treadmill exercise) is
also known as an influencing factor of hemodynamics especially
for submaximal levels of exercise (67, 68) and potentially adds
further heterogeneity to the data.
To overcome these hurdles, the importance of integrative
databases for cardiorespiratory stress testing like the US fitness
registry FRIEND has been highlighted. Kaminsky et al. recently
outlined the importance of new reference values, which can help
to improve the understanding of individual cardiorespiratory
fitness levels (69).
There were only a few studies reporting the pre-specified
parameters of interest for AS and even fewer for CoA. The
AS group included symptomatic and asymptomatic patients
with varying levels of AS, which may have contributed to
between-study heterogeneity. In particular studies with low-flow,
low-gradient situations, and LV-EF impairment (70, 71) were
analyzed separately as LV mechanics can impact circulatory
parameters. Nevertheless, the hemodynamic changes of HR and
SV between AS patients with and without low-flow, low-gradient
situations did not differ significantly. One study with paradoxical
low-gradient AS was not analyzed separately as LV function
was not impaired in this study (72). In CoA only very limited
evidence (4 studies) has been identified with (a) varying types of
exercise testing (b) with one study using isoproterenol instead
of dobutamine, and (c) without any data on isometric exercise.
Future research is still needed in both disease groups in order to
characterize the hemodynamic stress response. When assessing
hemodynamic changes in patients with AS or CoA, regular intake
of medication can be of importance. Unfortunately, an analysis
of the influence of this factor was not possible due to inconsistent
reporting of treatment (e.g., beta-blocker use) across studies.
Our attempt to classify stress intensity according to pre-
defined absolute parameters was challenging as study end points
varied greatly. While some focused on quantitative end points
such as watts or METs, other studies used levels of exhaustion.
METs have been subject to controversy discussions in the past
due to the finding of possibly overestimating resting oxygen
consumption (73), but they are still considered a useful tool to
quantify individual stress levels in clinical routine (74). Another
common criterion used by various investigators to classify stress
intensity was the percentage of age-predicted maximal heart
rate reached (HRmax), although it is known to be subject to
high individual variability (75) and results from big population
studies indicate that different approaches should be used in future
investigations (76).
CONCLUSION AND OUTLOOK
This meta-analysis describes the changes of HR, SV, CO
and SET induced by different stress types and intensity
levels. Despite limited direct comparability between studies,
age-dependent values are presented and can already provide
reference data of normal reactions in healthy individuals
and can be of use when comparing outcomes of commonly
performed stress tests. Furthermore, gaps in the available
evidence in both disease groups, in particular in CoA,
are clarified.
Disease-specific changes may also contribute to more detailed
patient-specific models and a better understanding in valvular
and congenital heart disease. Data may allow estimation of
the expected individual range of a circulatory response and
may thus contribute to future study planning and future
individualized diagnostic models, even when stress testing
is contraindicated.
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